Professor Mike Lean will give a public talk in Dunedin this month about type 2 diabetes. Professor Lean holds the chair of Human Nutrition, based at the Glasgow Royal Infirmary, where he is also a consultant physician. In 2014 he was one of only 19 Scottish researchers in the top 1% for international citations, on the Thomson-Reuters ‘Highly Cited’ Researcher listing.
Come and hear this highly regarded nutrition specialist speak about the Diabetes Remission Clinical Trial (DiRECT), the biggest research study ever funded by Diabetes UK, which aims to reverse the diagnosis of type 2 diabetes using a non-surgical weight management programme.
Abstract: Type 2 diabetes is increasing rapidly, world-wide, with the rise in overweight and obesity. It remains a devastating progressive disease, with 6-10 years reduced life expectancy, despite the application of modern clinical guidelines and multiple drug treatments. The only intervention with potential to interrupt the disease process is major weight loss (over 15kg for most) with physical activity if possible. This has been proved using bariatric surgery, which has its own complications and is costly and unacceptable to many patients. The Diabetes Remission Clinical Trial (DiRECT), the biggest research study ever funded by Diabetes UK, is evaluating an evidence-based structured non-surgical weight management programme with a view to reversing the diagnosis of type 2 diabetes. If it proves acceptable, effective, and cost-effective, this might shift the current pharmaceutical treatment paradigm, to become the primary management strategy for Type 2 diabetes.
More information from the University of Otago.
Download the poster here.